The PI3K-AKT-mTOR pathway is an important pathway underlying drug resistance induced by combined radiation and TKI therapy, and inhibiting mTOR can reverse this drug resistance in lung adenocarcinoma. Here, MTOR is linked to lung adenocarcinoma.